Could fortified beer and lassi tap into Asia’s soaring protein demand?
Asia’s demand for protein is soaring, but is the Indian market ready for protein-fortified beers and lassi?
Archives for August 24, 2016
R&D tax boost for Gordagen ahead of US nutraceutical launch
Australian nutraceutical firm Gordagen Pharmaceuticals is preparing to launch its heart health and endurance products in the US by the end of the year.
Cordyceps fungi supplementation may improve high-intensity exercise
Industry study suggests an increased tolerance of high-intensity training when study participants consumed the cordyceps-containing PeakO2 blend.
Embracing the future: The dietary supplement industry comes of age
Duffy MacKay of CRN argues that there is much in FDA's newly released New Dietary Ingredients draft guidance that represents a step forward for the industry.
Cardax puts synthetic astaxanthin finished product on market
A synthetic astaxanthin finished product has reached the market with the release of ZanthoSyn, by Hawaiian firm Cardax.
Can shrimp byproducts be a source of shelf-stable astaxanthin?
Carotenoid and astaxanthin production has been championed as a solution to make use of the crustacean industry’s waste. Researchers looked at the derived product’s storage stability—they found “negligible lipid oxidation” and some gradual degradation of...
‘We want to be the top superfood company in Poland’: Chlorella start-up
Polish start-up Purella Food is on a mission to popularise chlorella and it's arming itself with a vast portfolio of ‘superfood’ products for the battle.
Mimicking human breast milk: Another novel synthetic formula ingredient on the horizon?
Danish biotech firm Glycom has filed another application for a synthetic version of a compound found in breast milk, a development one infant formula expert said was promising.
DHA beats EPA for stroke-induced brain damage: Mice study
Omega-3s can reduce brain damage that occurs as a result of a stroke, a Columbia University study has found.
Literature from trade show booth puts company in hot water with FDA
A recent FDA warning letter emphasizes the importance of maintaining consistent messaging about a product to avoid crossing the disease claims line.